Immunothérapie Hilar fat infiltration Glioblastomas Base Sequence Clear cell renal carcinoma Temozolomide PD-1 blockades DNMT3A Array-CGH Chemotherapy Cancer stem cells Cellules immunes Metastasis DNA methylation Adenocarcinoma Cell therapy Hemochromatosis Cell Line Biomarkers Proteomics Biological Clear cell renal cell carcinoma BRAF Abortion Expression de PD-L1 Epidermal Growth Factor Receptor Molecular biology Chicken Epithelial mesenchymal transition Blast Crisis MiRNA Adipose tissue Angiogenesis Data integration Epitranscriptomics Immunotherapy BRAF mutation Cytotoxic T cells Colorectal cancer Prognosis Cancer-associated fibroblasts IRE1 Endoplasmic reticulum Aryl hydrocarbon Receptor 5q121 deletion Chemoradiotherapy CGH array Sunitinib Cell cycle arrest Survival Discoidin domain receptor 2 Anal canal carcinoma Antineoplastic Combined Chemotherapy Protocols DNA CHIP Predictive biomarker Drug therapy Checkpoint inhibitors Enterocytes Biomarker Cell proliferation CYP2C Immune system Clinical outcome EGFR DNA methylation signature B-Cell Cytosine-methylation Biomarkers France Translational study ANNOTATION MGMT PD-L1 expression Transcriptomics Bevacizumab Epidermoid lung carcinoma Glioma-CpGs island methylator phenotype Epigenetics AGO4 Kidney cancer Carcinoma Candidate loci Humans EZH2 CD73 Peritumoral brain zone Classification Anti-PD1 Glioblastoma Epidermal Growth Factor Contraception Computational Biology Prognostication Anti-EGFR mAb Prognostic CRISPR-SAM Epilepsy Antineoplastic Agents Biomarqueurs DNA Cancer